Assuming type is required, the following results were found.

  • Severe type I interferonopathy and unrestrained interferon signaling due to a homozygous germline mutation in STAT2 - Science

    Interferon Insight Uncontrolled type I IFN activity has been linked to several human pathologies, but evidence implicating this cytokine response directly in disease has been limited. Here, Duncan et al. identified a homozygous missense mutation in...

    https://mschristian.org/index.php/articles/2-uncategorised/9542-severe-type-i-interferonopathy-and-unrestrained-interferon-signaling-due-to-a-homozygous-germline-mutation-in-stat2-science
  • Severe type I interferonopathy and unrestrained interferon signaling due to a homozygous germline mutation in STAT2 - Science

    Interferon Insight Uncontrolled type I IFN activity has been linked to several human pathologies, but evidence implicating this cytokine response directly in disease has been limited. Here, Duncan et al. identified a homozygous missense mutation in...

    https://mschristian.org/index.php/blog/severe-type-i-interferonopathy-and-unrestrained-interferon-signaling-due-to-a-homozygous-germline-mutation-in-stat2-science
  • Removing a gene prevents Type 1 diabetes in mice by disguising beta cells

    by Emily Henderson, B.Sc.Mar 26 2020 Removing a gene from the cells that produce insulin prevents mice from developing Type 1 diabetes by sparing the cells an attack from their own immune system, a new UW-Madison study shows. The cellular...

    https://mschristian.org/index.php/articles/2-uncategorised/10541-removing-a-gene-prevents-type-1-diabetes-in-mice-by-disguising-beta-cells
  • Removing a gene prevents Type 1 diabetes in mice by disguising beta cells

    by Emily Henderson, B.Sc.Mar 26 2020 Removing a gene from the cells that produce insulin prevents mice from developing Type 1 diabetes by sparing the cells an attack from their own immune system, a new UW-Madison study shows. The cellular...

    https://mschristian.org/index.php/blog/removing-a-gene-prevents-type-1-diabetes-in-mice-by-disguising-beta-cells
  • ADA 2020 Roundup: Simponi Preserves Beta Cells in Kids With T1D

    New data highlighting advances in care for type 1 and type 2 diabetes were presented at the American Diabetes Association virtual meeting. Highlights reported by MedPage Today earlier in the week included the prevention of new-onset diabetes with...

    https://mschristian.org/index.php/ada-2020-roundup-simponi-preserves-beta-cells-in-kids-with-t1d
  • Researchers Identify Nerve Cells That Are Vulnerable to Damage in MS

    tissues from people who had MS in their lifetimes, before there were disease-modifying therapies.They report that a specific type of nerve cell called “projection neurons” – which normally facilitate communication between different areas of the brain –...

    https://mschristian.org/index.php/blog/researchers-identify-nerve-cells-that-are-vulnerable-to-damage-in-ms
  • Electronic Drug Delivery Systems Market Size Reach US$ 12.1 Billion by 2026 - Yahoo Finance

    of various devices are the key driving factors for the electronic drug delivery devices across the world. Based on product type, the market has been segmented into electronic wearable infusion pumps, electronic injection pens, electronic inhalers,...

    https://mschristian.org/index.php/blog/electronic-drug-delivery-systems-market-size-reach-us-12-1-billion-by-2026-yahoo-finance
  • What to know about neuralgia

    vessels, or tumors other medical conditions, such as kidney disease or diabetes aging This article covers the different types of neuralgia, their symptoms, and the treatment options available. Types of neuralgia Healthcare professionals divide neuralgia...

    https://mschristian.org/index.php/articles/2-uncategorised/8712-what-to-know-about-neuralgia-1
  • Electronic Drug Delivery Systems Market Size Reach US$ 12.1 Billion by 2026 - Yahoo Finance

    of various devices are the key driving factors for the electronic drug delivery devices across the world. Based on product type, the market has been segmented into electronic wearable infusion pumps, electronic injection pens, electronic inhalers,...

    https://mschristian.org/index.php/articles/2-uncategorised/9073-electronic-drug-delivery-systems-market-size-reach-us-12-1-billion-by-2026-yahoo-finance
  • 2025 Projections: Multiple Sclerosis Industry Market Report by Type, Application and Regional Outlook - AlgosOnline

    market share that each geography holds at present.The study is inclusive of details related to the gross margins, price prototypes, etc., conjunction with the consumption projections. Ask for Discount on Multiple Sclerosis Industry Market Report at:...

    https://mschristian.org/index.php/2025-projections-multiple-sclerosis-industry-market-report-by-type-application-and-regional-outlook-algosonline
  • B cells among factors leading to brain lesions in multiple sclerosis

    multiple sclerosis, it is not only specific T cells that cause inflammation and lesions in the brain. B cells, a different type of immune cell, also play a role. These cells activate T cells in the blood. This discovery explains how new MS drugs take...

    https://mschristian.org/index.php/blog/b-cells-among-factors-leading-to-brain-lesions-in-multiple-sclerosis
  • What to know about secondary progressive multiple sclerosis (SPMS)

    condition that causes the immune system to mistakenly attacks the nerve cells in the central nervous system. The most common type of MS is RRMS, which is the stage before SPMS. According to the National Multiple Sclerosis Society, most people with RRMS...

    https://mschristian.org/index.php/blog/what-to-know-about-secondary-progressive-multiple-sclerosis-spms-1
  • Global Multiple Sclerosis Market by Types, Applications, Countries, Companies and Forecasts to 2024 covered in a Latest Research - Market Research Reporting

    Report Details at: https://www.themarketreports.com/report/global-multiple-sclerosis-market-by-manufacturers-countries-type-and-application-forecast With the help of 15 chapters spread over 100 pages this report describe Multiple Sclerosis Introduction,...

    https://mschristian.org/index.php/blog/global-multiple-sclerosis-market-by-types-applications-countries-companies-and-forecasts-to-2024-covered-in-a-latest-research-market-research-reporting
  • Multiple Doses of Stem Cells Show Potential in Treating Severe Asthma - Yahoo Finance

    de Janeiro and the National Institute of Science and Technology for Regenerative Medicine describe how multiple doses of a type of stem cell called mesenchymal stromal cells (MSCs) might offer a new way to treat people suffering from severe asthma....

    https://mschristian.org/index.php/blog/multiple-doses-of-stem-cells-show-potential-in-treating-severe-asthma-yahoo-finance
  • Primary Progressive Multiple Sclerosis Treatment Market Studied by 2019-2027 with Profiling Player - Market Research Sheets

    displays the sales volume(K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into Type 1, Type 2, Type 3, so on. On the basis on the End users/Applications: This report focuses on the...

    https://mschristian.org/index.php/blog/primary-progressive-multiple-sclerosis-treatment-market-studied-by-2019-2027-with-profiling-player-market-research-sheets
  • Why is my leg shaking?

    They are often those that damage the neurological system, including: Liver and kidney failure may also cause tremors. A rare type of tremor, called primary orthostatic tremor, specifically affects the legs. People with this condition notice a sudden...

    https://mschristian.org/index.php/articles/2-uncategorised/9237-why-is-my-leg-shaking
  • Primary Progressive Multiple Sclerosis Treatment Market Studied by 2019-2027 with Profiling Player - Market Research Sheets

    displays the sales volume(K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into Type 1, Type 2, Type 3, so on. On the basis on the End users/Applications: This report focuses on the...

    https://mschristian.org/index.php/articles/2-uncategorised/9642-primary-progressive-multiple-sclerosis-treatment-market-studied-by-2019-2027-with-profiling-player-market-research-sheets
  • What's New in Stem Cells? Expert Discusses Hematopoietic Status and Newer Mesenchymal Approaches

    experimental approach, or a dubious sham treatment preying on unwary patients. So, which is correct? This depends upon which type of SCT one is discussing. Mark S. Freedman, MSc, MD, Professor of Neurology at the University of Ottawa in Ontario, Canada,...

    https://mschristian.org/index.php/what-s-new-in-stem-cells-expert-discusses-hematopoietic-status-and-newer-mesenchymal-approaches
  • Kazakhstan Refutes Reports of Deadly Illness. What to Know

    in the Central Asian country. Today, the health ministry in Kazakhstan put out a statement denying that there’s a new type of pneumonia outbreak. Share on PinterestHealth officials disinfect playground equipment. Getty Images Health officials in...

    https://mschristian.org/index.php/kazakhstan-refutes-reports-of-deadly-illness-what-to-know
  • Research explains why many psychiatric drugs that work in the lab don’t work in people

    the Allen Institute for Brain Science, Seattle, seems to have found at least part of the answer. The study compared the cell types in one part of the brain between mice and humans to produce the first-ever detailed classification of each cell type, and...

    https://mschristian.org/index.php/blog/research-explains-why-many-psychiatric-drugs-that-work-in-the-lab-don-t-work-in-people

Results 1 - 20 of 153